These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6099820)

  • 1. [Resistance spectrum of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H; Wagner J
    Immun Infekt; 1983 Jun; 11(4):140-2. PubMed ID: 6099820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spectrum of resistance of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H; Wagner J
    Immun Infekt; 1983 Jun; 11(4):140-2. PubMed ID: 6327506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activities of cefotiam against various pathogens isolated from clinical materials (author's transl)].
    Murase M; Niiya T; Katayama Y; Takeuchi N
    Jpn J Antibiot; 1982 Apr; 35(4):1004-8. PubMed ID: 6285018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Thabaut A; Meyran M; Chanal M; Cluzel M; Brun Y; Coulet M; Fleurette J
    Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antibacterial efficacy of cefaclor in routine testing of clinical material from two Berlin hospitals (author's transl)].
    Wagner J; Hahn H
    Infection; 1979; 7 Suppl 6():547-50. PubMed ID: 121730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbiologic and clinical significance of cefotiam].
    Tauchnitz C; Ezold R; Bauer I; Berger HD; Buhl C; Goedecke A; Morawietz I
    Z Gesamte Inn Med; 1985 Mar; 40(5):143-8. PubMed ID: 3857792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of cefotiam against bacteria of clinical interest.
    Watt B; Brown FV
    J Antimicrob Chemother; 1982 Nov; 10(5):391-5. PubMed ID: 6294043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamental and clinical studies of cefotiam in the field of pediatrics (author's transl)].
    Akita H; Iwasaki Y; Iwata S; Kanemitsu T; Hattori H; Jozaki K; Hotta M; Yamashita N; Nanri S; Kojima Y; Hara N; Sunakawa K; Oikawa T; Iwata T; Osano M; Ichihashi Y
    Jpn J Antibiot; 1981 May; 34(5):723-8. PubMed ID: 6270415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model.
    Wiedemann B; Seeberg AH
    J Antimicrob Chemother; 1984 Feb; 13(2):111-9. PubMed ID: 6323374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies of cefotiam in the field of pediatrics (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M
    Jpn J Antibiot; 1981 May; 34(5):690-704. PubMed ID: 6270411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of cefotiam against clinical isolates in the field of obstetrics and gynecology].
    Deguchi K
    Jpn J Antibiot; 1983 Apr; 36(4):678-88. PubMed ID: 6308295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.